Covariates | Summary-Level Modified Poisson Method | Pooled Individual-Level Data Analysis | ||
---|---|---|---|---|
Parameter Estimates | Standard Errors | Parameter Estimates | Standard Errors | |
Intercept | −1.5653147 | 0.1040146 | −1.5653147 | 0.1040146 |
Exposurea | −0.4632219 | 0.0422368 | −0.4632219 | 0.0422368 |
Demographics | ||||
 Age (years) | 0.0029253 | 0.0018694 | 0.0029253 | 0.0018694 |
 Female sex | 0.0860355 | 0.0478638 | 0.0860355 | 0.0478638 |
Combined comorbidity score | 0.0543412 | 0.0125169 | 0.0543412 | 0.0125169 |
Diagnosis of | ||||
 Asthma | −0.0212109 | 0.0538624 | −0.0212109 | 0.0538624 |
 Atrial fibrillation | 0.0835820 | 0.1249359 | 0.0835820 | 0.1249359 |
 Atrial flutter | 0.1638268 | 0.2598721 | 0.1638268 | 0.2598721 |
 Coronary artery disease | 0.1597157 | 0.0746721 | 0.1597157 | 0.0746721 |
 Deep vein thrombosis | 0.1738365 | 0.1371837 | 0.1738365 | 0.1371837 |
 Gastroesophageal reflux disease | −0.0586971 | 0.0393428 | −0.0586971 | 0.0393428 |
 Hypertension | 0.0046885 | 0.0448018 | 0.0046885 | 0.0448018 |
 Ischemic stroke | −0.1592596 | 0.1986055 | −0.1592596 | 0.1986055 |
 Myocardial infarction | 0.2069423 | 0.1509918 | 0.2069423 | 0.1509918 |
 Pulmonary embolism | 0.2846648 | 0.1436404 | 0.2846648 | 0.1436404 |
 Sleep apnea | −0.0261550 | 0.0396516 | −0.0261550 | 0.0396516 |
Use of | ||||
 Anticoagulants | 0.1064905 | 0.1205252 | 0.1064905 | 0.1205252 |
 Assistive walking device | 0.0908909 | 0.1394227 | 0.0908909 | 0.1394227 |
 Home oxygen | 0.0732620 | 0.1162295 | 0.0732620 | 0.1162295 |
Number of drug dispensing | ||||
 Unique drug classes | −0.0579458 | 0.0166577 | −0.0579458 | 0.0166577 |
 Unique generic medications | 0.0673783 | 0.0136406 | 0.0673783 | 0.0136406 |